Table 3 Correlation between serum levels of sRAGE and FF sRAGE, and demographic and clinical characteristics of the patients in the PCOS and control groups
| Â | Age (year) | Body mass index (kg/m2) | ||
|---|---|---|---|---|
r | p-value* | r | p-value* | |
PCOS | ||||
 Serum sRAGE (ng/mL) | 0.093 | 0.714 | 0.318 | 0.198 |
 FF sRAGE (ng/mL) | -0.532 | 0.019* | 0.463 | 0.046* |
Non-PCOS | ||||
 Serum sRAGE (ng/mL) | 0.255 | 0.217 | 0.209 | 0.306 |
 FF sRAGE (ng/mL) | 0.255 | 0.228 | -0.296 | 0.160 |
Total | ||||
 Serum sRAGE (ng/mL) | 0.171 | 0.268 | 0.241 | 0.116 |
 FF sRAGE (ng/mL) | -0.346 | 0.023* | 0.361 | 0.017* |